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Summary
Regulatory T cells play a crucial role in normal gut homeostasis, as well as
during infection with microbial or parasitic pathogens. Prior to infection,
interactions with the commensal microflora are essential to differentiation of
a healthy steady-state level of immunoregulation, mediated through both
Toll-like receptor-dependent and -independent pathways. The ingress of
pathogenic organisms may, according to the context, promote or reverse the
regulatory environment, with onward consequences for inflammation in both
the intestinal and extra-intestinal settings. Appropriate regulation of gut
immunity thus depends upon a complex three-way interplay between host
cells, commensals and pathogens, and can exert a major impact on systemic
responses including allergy and autoimmunity.
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Introduction
In the gastrointestinal (GI) tract, the immune system is faced
with the most demanding of all decision-making, with little
room for error. It is imperative at all times to discriminate
between, and respond correctly to, beneficial symbionts,
harmless food antigens and potential pathogens [1]. There is
increasing appreciation that regulatory T cells (Tregs) play a
prominent and essential role in maintaining appropriate
responsiveness in the gut [2,3], actively enforcing homeosta-
sis and preventing untoward immune responses occurring.
While stimulated by specific antigens, of both self and non-
self origin, Tregs can transcend antigen specificity, mediating
bystander suppression in a manner likely to modify systemic
immune status as suggested by the ‘hygiene hypothesis’.
The steady-state: commensals, no infection
Recent studies have changed our perspective of commensal
microbes from benign but inert passengers to active partici-
pants in both the postnatal development of mucosal immu-
nity and in its long-term steady-state function. Germ-free
mice show extensive deficiencies in intestinal immune
system development, with reduced lymphoid tissue and
fewer lymphocytes [4]. The CD4+ T cell population is dimin-
ished, affecting T helper type 1 (Th1) cells disproportion-
ately although, remarkably, Treg frequencies are maintained
or increased in germ-free mice. These and other data have
established that defined components of the gut flora can play
a major role in intestinal homeostasis, including protection
against gut injury and mediating oral tolerance against
dietary antigens.
In mice which acquire a conventional microbiome, the
immune system develops normally while maintaining a con-
tinuing dialogue with the commensal population. Here, one
of the dominant roles of Tregs is to prevent exuberant
responses against gut flora, with which the intestinal tract is
in intimate contact. Nevertheless, how commensals commu-
nicate with cells to ensure immune homeostasis is still
unclear. One critical factor in this interaction at the molecu-
lar level is the host Toll-like receptor (TLR) system, as dem-
onstrated by spontaneous colitis in TLR-5-deficient mice
[5]. Where colitis is induced experimentally (e.g. by dextran
sulphate administration), the absence of TLR signalling then
results in greatly aggravated pathology, again indicating that
TLR-mediated recognition of commensal molecules con-
tributes to dampening immune reactivity [6]. The require-
ment for TLR signalling in induction of oral tolerance to
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dietary antigens [7] also speaks to the bimodal participation
of the TLR system in both stimulatory and regulatory arms
of the immune response.
Recent evidence suggests that TLR signalling can impact
Treg homeostasis and that Tregs themselves express TLRs
selectively. Hence, interaction with certain ligands, such as
those binding TLR-2, can favour Treg expansion both in vitro
and in vivo [8], while TLR-9-mediated recognition of DNA
from gut flora is an essential step in ensuring that effector T
cells are able, when appropriate, to overcome Treg inhibition
and mount an immune response [9].
Alteration of the structural integrity of TLR signalling
components is often associated with profound clinical
outcome and susceptibility to various infections or autoim-
mune disorders. During conditions of floral translocation,
peripheral TLR-9 signalling is a crucial mediator of polymi-
crobial sepsis. Moreover, in other conditions in which bac-
terial translocation occurs [for example, during irradiation
and human immunodefiency virus (HIV) infection] periph-
eral TLR-4 signals enhance the activation status of both
CD4+ and CD8+ T cells [10]. However, under most circum-
stances the tissues of the GI tract are exposed constantly to
TLR ligands harboured by the commensal gut flora.
Mice deficient in TLR-9 display increased frequencies
of Tregs within intestinal effector sites and reduced levels of
constitutive interleukin (IL)-17- and interferon (IFN)-g-
producing effector T cells [9]. Complementing this, lamina
propria dendritic cells (DCs) lacking exposure to gut flora
DNA, induce Treg conversion in vitro. Furthermore, Treg
versus effector T cell disequilibrium in TLR-9-/- mice restricts
immune responses to oral infection with the pathogen
Encephalitozoon cuniculi. Impaired intestinal immune
responses were recapitulated in mice treated with antibiotics
and were reversible after reconstitution with gut flora DNA
[9]. Thus, signals derived from the gut flora act as adjuvants
of immune responses for priming intestinal responses
against oral pathogens via modulation of the equilibrium
between Treg and effector T cells.
Intestinal epithelial cell (IEC) expression of TLRs has also
proved to be important in maintaining the homeostatic
host–microbiome relationship, and to involve unexpected
subtleties. For example, TLR-9 is expressed on both the
apical (luminal-facing) and basolateral surfaces of the epi-
thelial cell layer, but only basolateral ligation triggers an
inflammatory signal, while apical binding is inhibitory [11].
The capacity of IECs to control immune responsiveness
extends to the production of thymic stromal lymphopoietin
(TSLP) and IL-25, influencing the Th phenotype balance in
a manner which can make or break effective immunity [12].
Not all commensals are equal
The structure and composition of the gut flora reflect
natural selection at both the microbial and host levels, and
show perturbations in GI dysfunction. For example, modi-
fied gut floral composition is found in inflammatory bowel
disease (IBD) patients [13]. Furthermore, the presence of
certain bacteria can aggravate small intestinal immunopa-
thology following oral infection. There can be exquisite
specificity in the effects of individual commensal species; for
example, within the genus Lactobacillus different species are
associated with differing in vivo allergic status in infants [14]
and contrasting capacity to induce regulatory cytokines in
vitro [15]. Moreover, even different strains or mutants of
particular Lactobacillus species stimulated very different
immunological outcomes in mice [16,17].
Recent evidence demonstrates that colonization of germ-
free mice with complex microbiota orchestrated a broad
spectrum of Th1, Th17 and Treg responses. Whereas most
tested individual bacteria failed to stimulate intestinal T cell
responses efficiently, a restricted number of individual bac-
teria can control the tonicity of the gut immune system [18].
The key commensal organisms in immune system develop-
ment have been identified very recently as segmented fila-
mentous bacteria [18,19]. A further reflection of how the
make-up of the intestinal flora can impact upon systemic
responses is found in studies of non-obese diabetic (NOD)
mice, which succumb spontaneously to type 1 diabetes
(T1D); it has been known for some time that higher micro-
bial exposure militates against development of this autoim-
mune disease [20], but it was shown recently not only that
conventionally housed myeloid differentiation primary
response gene 88 (MyD88)-/- mice are resistant to T1D, but
that resistance to disease is due to the distinct microbial
combination with which they are colonized. Hence,
MyD88-/- mice develop T1D under germ-free conditions,
while wild-type mice given the microbial population from
MyD88-/- animals had reduced susceptibility to disease [21].
It is tempting to speculate that alteration of Treg homeo-
stasis mediated by TLR signalling, either because of genetic
polymorphism or because of changes in gut flora composi-
tion, could also have consequences on development of gut
inflammatory disorders. Indeed, gut flora bacteria are not
equal in their capacity to stimulate TLR-9 and do so with
various levels of efficiency that correlate with the frequency
of cytosine–guanine dinucleotides. Thus, control of the Treg
ratio and effector T cell function in the GI tract is likely to be
regulated differentially by specific gut flora species. An illus-
tration of how the presence of defined bacterial species can
influence the outcome of an infection comes from the obser-
vation that mice fed Bifidobacterium infantis are protected
from the pathogenic effect and translocation of Salmonella
[22]. Activation of Tregs by the probiotic microorganism con-
tributed to this protective effect.
Can commensals regulate pathology?
The proposition that certain commensal species may act in a
counterinflammatory manner has led to extensive investiga-
tion of potential probiotic regulation of immunopathology.
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Promising results have been obtained with probiotics in the
treatment of human inflammatory diseases of the intestine
and in the prevention and treatment of atopic eczema in
neonates and infants, but mechanism(s) of action remain to
be elucidated [23]. In mice, probiotic Lactobacillus and/or
Bifidobacterium treatment suppressed trinitrobenzene sul-
phonic acid (TNBS)-induced colitis [24,25], as well as
allergy, while raising transforming growth factor (TGF)-b
production [26] and stimulating Tregs able to transfer down-
modulation of allergy [27]. There is also good evidence of
probiotic modulation of DCs towards a proregulatory func-
tion [15,28]. Of course, not all commensals are down-
regulatory, and some (like Helicobacter hepaticus) may be
pathogenic in some settings, yet induce Tregs in others [29].
Furthermore, there can be significant interactions between
pathogens, as in the example of intestinal bacteria aggravat-
ing the immunopathology caused by Toxoplasma infection
[30]. In the latter setting, there is reduced floral complexity,
either because of relative loss of more ‘regulatory’ strains or
simply as a broad reflection of an altered homeostasis
accompanying pathogenesis.
One consequence of the immune system’s reliance on
microflora for optimal immunoregulation is that antibiotic
therapies may result in unintended activation of immune
effector mechanisms. In model systems, antibiotic treatment
renders mice more susceptible to induction of food allergy
[7] as well as allergic airway inflammation [31]. For the
human population, antibiotics are seen as major modifiers of
beneficial human–microbe interactions [32] superimposed
upon alterations caused by other exogenous factors includ-
ing urbanization, global travel and dietary changes [33]. The
acute effects of antibiotic treatment on the native gut micro-
biota range from self-limiting diarrhoea to life-threatening
pseudomembranous colitis induced by bacteria filling the
niche provided by the reduction in bacterial diversity [34].
The long-term consequences of such perturbations for the
human–microbial symbiosis are more difficult to discern,
but chronic conditions such as asthma and atopic disease
have been associated with childhood antibiotic use and an
altered intestinal microbiota [35–37].
Because many chemical transformations in the gut are
mediated by specific microbial populations, with implica-
tions for, among others, cancer and obesity, changes in the
composition of the gut microbiota could have important but
undiscovered health effects. In this regard, ciprofloxacin
treatment of healthy volunteers influenced the abundance
of about a third of the bacterial taxa in the gut, decreasing
the taxonomic richness, diversity and evenness of the
community. However, the magnitude of this effect varied
among individuals, and some taxa showed interindividual
variation in the response to ciprofloxacin. In each individual,
the taxonomic composition of the community closely
resembled its pretreatment state by 4 weeks after the end of
treatment, but several taxa failed to recover within 6 months
[38].
The production of active anti-inflammatory mediators by
particular commensal species (reviewed in [39]) provides a
mechanistic framework for microbial regulation of pathol-
ogy in the GI tract. One of the most striking examples is the
zwitterionic polysaccharide A of Bacterioides fragilis, which
restores CD4+ T cell numbers in germ-free mice [40] and
protects mice against Helicobacter-induced colitis with the
induction of IL-10-producing Tr1 cells [41]. Hence, immu-
noregulation may revolve around highly specific host–
microbial molecular interactions, presumably reflecting
a long and intimate co-evolution of the symbiotic
relationship.
De novo induction of Tregs in the GI tract
The vitamin A metabolite, retinoic acid (RA), plays a major
role in the GI tract, via its capacity to enhance the TGF-b-
mediated generation of forkhead box P3 (FoxP3+) Tregs from
naive T cells by gut DCs [42]. Reciprocally, RA can inhibit
the generation of Th17 cells [43], suggesting that it may play
an important role in maintaining the balance between effec-
tor and regulatory populations in the GI tract. Several popu-
lations of mucosal APC can induce Tregs via RA, although
only the CD103 subset is equipped with the enzymatic
machinery to generate RA.
Retinoic acid can also imprint gut homing molecules on
various populations of lymphocytes. Defined microenviron-
ments may have evolved self-contained strategies in which
local mediators (such as RA) can imprint homing properties
while also favouring the induction or function of Tregs. It is
therefore tempting to speculate that a link between homing
and regulatory function induction may represent a more
general mechanism. Such a strategy could allow the constant
generation and migration of Tregs to defined compartments.
These Tregs would be expected to have the prerequisite
antigen specificities (e.g. persistent microorganisms, flora
antigens), status of activation and survival requirement that
allow them to regulate a defined microenvironment.
Although the capacity of gut-associated lymphoid tissue
(GALT) DCs or macrophages to imprint gut-homing recep-
tors and induce FoxP3+ Tregs is associated with their capacity
to release RA, it remains unclear if these cells are the main
producers of this metabolite in the gut. Synthesis of RA from
stored or dietary retinol depends on the direct expression of
the appropriate enzymes by GALT DCs. Certainly, DCs from
Peyer’s patches and mesenteric lymph nodes (MLNs) express
Aldh1a1 and Aldh1a2, respectively, and CD103+ DCs from
the lamina propria express a large array of this family of
enzymes; moreover, Peyer’s patch and MLN DCs can convert
retinol directly to RA in culture. However, other cells, includ-
ing IELs, can express enzymes associated with vitamin A
metabolism, suggesting that DCs may also acquire retinoic
acid from other sources and store it. A recent study demon-
strated that monocyte-derived DCs pretreated with RA can
acquire several attributes characteristic of mucosal DCs,
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such as secretion of TGF-b and IL-6, and the capacity to
augment mucosal homing receptor expression and IgA
responses in lymphocytes [44]. In this particular study, these
gut-derived features acquired by DCs were associated with
the capacity of DCs to become carriers and not producers of
RA. The precise factors that govern the activation of some of
these enzymes as well as how inflammation or infections
modify the metabolism of vitamin A remain to be explored.
Importantly, how commensals contribute to the expression
of these enzymes and metabolism of vitamin A remains
unknown. Another important question is the timing neces-
sary for DCs migrating in the GALT to acquire RA from
epithelial cells and how these processes can be modified
during infection. How RA contributes to oral tolerance, and
at the same time protective immunity in the GI tract, also
remains to be addressed. One possibility is that RA favours
the induction of Tregs in the absence of secondary signals but
enhances effector responses following exposure to inflam-
matory mediators.
Treg populations require not only appropriate conditions
for their induction, but also for their upkeep, particularly
when confronted with an inflammatory environment. Very
recently it has been shown that, in the gut, myeloid cell-
derived IL-10 plays a crucial role in maintaining functional
Treg activity by stimulating IL-10R directly on FoxP3+ Tregs
and allowing them to play a fully protective role in the pre-
vention of colitis [45]. Thus, in the absence of either innate
IL-10 production, or IL-10R on Tregs, these cells lose the
ability to block colitogenic effector T cells from causing
inflammatory disease, and indeed succumb themselves to
the inflammatory process by switching to the production of
IFN-g [45]. Hence, IL-10 is important for the maintenance of
Treg activity and can be pivotal at the tipping-point between
regulation and inflammation.
Systemic effects of GI regulation
The regulation of Treg activity between the gut and the
periphery is also of special interest, as IBD in humans may
affect extraintestinal organs in up to 36% of cases [46]. IBD-
related extraintestinal disorders are not specific to IBD. They
can be classified into reactive manifestations dependent
directly upon intestinal disease. The often co-existing pre-
sentation in the same patient points towards common
underlying pathomechanisms that may involve enteric flora
activating the immune system to turn against bacterial anti-
gens and, based on cross-reactivity, against intestinal anti-
gens and antigens in extraintestinal organs (‘molecular
mimicry’).
A separate subset of IBD patients shows an increased fre-
quency of other common autoimmune diseases that mani-
fest mainly independently of the bowel disease. This may
thus reflect susceptibility to autoimmunity in general.
The complex relationship between intestinal and extraint-
estinal manifestations in IBD is also reflected by the complex
multi-genetic control reported in animal models of IBD;
genetic loci regulating intestinal and extra-intestinal mani-
festations are largely but not exclusively different [47].
Parasite infection: pro- or counter-regulatory?
The appearance of GI parasites is a major challenge to the
discriminatory powers of the immune system, and one
which in evolutionary time has been played out countless
times. The host rarely fails to respond to the infection, but
the outcome in terms of response mode (Th1, Th2, Th17)
and the degree of Treg activation varies markedly according
the pathogen in question. In recent years, good experimental
data has been provided to show that host regulatory path-
ways are activated by certain GI parasites in particular
helminths. For example, the duodenal-dwelling nematode
Heligmosomoides polygyrus can inhibit gut inflammation in
the mouse associated with Helicobacter colitis [48], genetic
IL-10 deficiency [49] or peanut allergy [50]; the same para-
site stimulates Treg expansion and induction in vivo and in
vitro [51–53]. In Trichuris muris infections of the colon, Tregs
are required to minimize intestinal pathology and the para-
site strain able to survive longest in the mouse is associated
with the largest numerical expansion in Tregs [54].
Although data from human helminth infections are not so
definitive, new and remarkable evidence has been provided
for the presence of GI helminth-associated Tregs. A cohort of
multiple sclerosis patients were found to have acquired gut
helminth infections while under longitudinal monitoring in
the clinic; infected individuals showed a dramatically lower
rate of relapse, with milder clinical scores, than case–
controlled uninfected patients. Infected subjects showed
higher correlates of Treg activity and lower inflammatory
cytokine production on autoantigen stimulation, linking the
helminth infection with expanded Treg activity and improved
clinical outcome [55].
Studies to date have not been defined whether the Treg
subsets stimulated by GI helminths are natural or induced,
or if there are parasite-specific Treg populations among them.
In addition, the relative importance of Tr1 (non-FoxP3-
expressing, IL-10-producing) regulatory cells is brought into
question by the dispensible nature of IL-10 for many
helminth-associated regulatory effects (for example [56]).
By contrast, new data are clearly demonstrating an inherent
capacity to promote induced Treg development and function
in the case of H. polygyrus secretions which drive de novo
expression of FoxP3 in naive peripheral T cells.
The distinction between Tregs and inducible regulatory T
cells in vivo is not always clear, particularly in highly inflam-
matory settings. Moreover, Tregs may be able to influence the
emergence or function of one another. This notion was sug-
gested recently in a model of Aspergillus conidia infection in
mice. In this model, control of allergic immunopathology
induced by the fungus required the sequential activity of
various populations of Tregs [57]. This sequential role for
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various populations of Tregs may not be an exception but
rather the rule, as most infections proceed through various
stages and therefore require various layers of regulation.
The host, on the other hand, has many mechanisms which
may uphold or restore responsiveness in a counter-
regulatory fashion. For example, upon infectious challenge
the gut-resident APC are likely to be replaced by inflamma-
tory cells that have not been conditioned by the gut environ-
ment [58]. Previous reports examining both gut and lung
inflammation support the idea that restricted or defective
Treg conversion can enhance immunopathology [59]. Such
limitations of conversion during inflammation raise the pos-
sibility that exposure to antigen at a time of acute infection
may impair the acquisition of tolerance against commensals
that could, in turn, contribute further to the pathological
process. Whatever the mix of factors at play, it is clear that
regulation by pathogens is a dynamic process and, under the
right circumstances, host immunity can reassert itself to
overcome the infection.
Systemic consequences and long-term effects
of GI infections
If changes in the commensal population within the GI tract
impact upon systemic immune responses, as discussed
above, then it is not surprising to find that parasitic infec-
tions in the same milieu can also exert substantial systemic
effects. The influence of infection on ‘bystander’ responses,
particularly where mediated through various regulatory cell
populations, provides a mechanistic explanation of the more
general ‘hygiene hypothesis’ concept that increasing rates of
allergy and asthma in western countries could be the conse-
quence of reduced infectious stresses during early childhood
[60].
Experimental work has lent strong support for this
hypothesis. For example, during GI infection, helminth-
driven Treg suppression of effector function protects against
subsequent airway inflammation [56]. Similar infections
change responses to blood-stage malaria [61] and interfere
with vaccinations [62,63]. Evidence for bystander suppres-
sion in human GI helminth infection is also accumulating,
with lower allergy rates in infected children [64,65], and
lower inflammatory responses to autoantigen in the multiple
sclerosis study mentioned above [55]. Indeed, helminth
therapy is being trialled as a potential strategy to ameliorate
intestinal inflammation in Crohn’s disease and ulcerative
colitis [66]. Notably, other suppressive cell types are observed
in these infections, including ‘regulatory B cells’ and alterna-
tively activated macrophages, although the interdependence
and sequence of activation of these other regulatory compo-
nents have yet to be discerned [67].
Pathogens may therefore have evolved to exploit, and even
imitate, our symbiotic relationship with gut flora. As
described above, probiotic microorganisms have beneficial
effects in the treatment of inflammatory bowel diseases
through the induction of Treg populations, and evidence is
now emerging that some helminths can act similarly. As with
commensal microbes, different helminths exert very differ-
ent immunological effects and some appear to be less adept
in anti-inflammatory action than others, as ongoing research
is now establishing.
The presence of symbiotic and pathogenic microorgan-
isms in the gut or other peripheral tissues could lead to the
maintenance of a pool of activated Tregs (both natural and
inducible) that would maintain host immune homeostasis
and enhance the threshold required for immune activation
and induction of an immune response. The benefit of such
deactivation is to decrease the instances of aberrant immune
responses, such as allergic and autoimmune disorders.
Pathogenic microorganisms may also have evolved to express
antigens that cross-react with gut flora antigens. In infec-
tions, the removal or modification of the gut flora is associ-
ated with a modification of the phenotype of the host
responses. Therefore, some microorganisms may hijack Tregs
that are induced or activated in the gut to limit pathogenic
responses against gut flora to ensure their own survival.
Over time, established GI infections may create a new
homeostatic set point, in which reactivity to the chronic
pathogen is minimized, with wider implications for respon-
siveness to self-antigens and allergens which may not be
altogether detrimental. At this point, it remains unclear to
what extent any recalibration of host immunity is induced
purely by the pathogen, or by perturbation of the commen-
sal population, or is a result of endogenous controls within
the immune system itself. On the basis of both human and
experimental studies discussed above, it seems likely that all
three components play an essential role in reaching a stable
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